How is Galactosemia diagnosed?

Galactosemia is primarily diagnosed shortly after birth through newborn screening programs that measure galactose-1-phosphate uridyltransferase (GALT) enzyme activity in a blood sample. If screening results are abnormal, a definitive diagnosis is confirmed through quantitative enzyme assays and molecular genetic testing to identify specific mutations in the GALT gene.

How is Galactosemia diagnosed in newborns and infants?

The diagnostic pathway for Galactosemia typically begins with a mandatory newborn screening (NBS) test, which detects elevated levels of galactose in the blood. Because Galactosemia is a medical emergency, rapid confirmation is essential. Once an initial screen is flagged, the clinical team performs a quantitative assay to measure GALT enzyme activity in red blood cells. In classic Galactosemia, enzyme activity is typically absent or severely reduced (less than 1% of normal levels). Furthermore, clinicians will conduct urine tests to detect the presence of galactitol, a byproduct that accumulates when the body cannot process galactose.

What is the role of genetic testing?

Genetic testing is a critical component of the diagnostic process for Galactosemia. While enzyme assays confirm the biochemical defect, molecular testing identifies the specific pathogenic variants within the GALT gene. This is especially important for family planning and understanding the specific type of Galactosemia (such as the Duarte variant, which is often milder). Genetic counselors are vital during this phase to help families interpret these results and understand the inheritance pattern, which is autosomal recessive.

What conditions can be confused with Galactosemia?

The diagnostic odyssey for Galactosemia can be challenging because early symptoms—such as jaundice, poor feeding, lethargy, and liver dysfunction—overlap with several other conditions. Clinicians must perform a differential diagnosis to rule out:

• Severe neonatal sepsis: Often presents with similar systemic illness and jaundice.


• Liver disease/biliary atresia: Can mimic the jaundice and liver enzyme elevation seen in Galactosemia.


• Other metabolic disorders: Conditions like fructose intolerance or tyrosinemia may present with comparable metabolic disturbances.


• Galactokinase deficiency: A separate form of galactose metabolism disorder that primarily causes cataracts rather than systemic organ failure.

Why is it important to seek a specialist?

We recognize that the diagnostic journey can be incredibly isolating, and it is common for families to feel frustrated by delays or misdiagnoses. Because Galactosemia is rare, many general practitioners may not have encountered it in their clinical practice. It is imperative to consult with a metabolic specialist or a pediatric endocrinologist who understands the nuances of this condition. At DiseaseMaps.org, we have 142 community members who have navigated this path; their experiences highlight that early intervention by a specialist is the single most significant factor in preventing long-term complications.

Next steps

• Consult a board-certified metabolic geneticist or pediatric metabolic specialist to review diagnostic findings.


• Request a referral to a metabolic dietitian who specializes in galactose-restricted diets.


• Join the DiseaseMaps.org community to connect with other families who have experience with the diagnosis and management of this condition.


• Ensure that genetic testing results are shared with all first-degree relatives for appropriate carrier screening.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Galactosemia overview.


• Orphanet: Rare disease database entry for Classic Galactosemia.


• OMIM (Online Mendelian Inheritance in Man): GALT gene and associated clinical phenotypes.


• Galactosemia Foundation: Clinical guidelines for patients and caregivers.